# Fulcrum Therapeutics, Inc.: Form DEF 14A, filed Apr 30, 2025

- Company: [Fulcrum Therapeutics, Inc.](/companies/fulc.md) (CIK 1680581)
- Form: DEF 14A
- Filed: 2025-04-30
- Accepted by EDGAR: Apr 30, 2025, 16:00 ET
- Period: 2025-04-25
- Accession: 0000950170-25-061000
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1680581/000095017025061000/fulc-20250425.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1680581/000095017025061000/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1680581/000095017025061000/fulc-20250425.htm

Filed Apr 30, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-061000. Last ingested by Listed: Nov 4, 2026, 17:36 ET. No prices; not investment advice.